Successful long-term erythrocytapheresis therapy in a patient with symptomatic sickle-cell disease using an arterio-venous fistula

Transfusion Medicine

Volumn 12, Issue 1, 2002, Pages 75-77

  Hartwig, D ^a   Schlager F ^a   Bucsky, P ^a   Kirchner, H ^a   Schlenke, P ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Arterio venous fistula; Erythrocytapheresis; Sickle cell disease

Indexed keywords

ADOLESCENT; ALLOIMMUNIZATION; ARTERIOVENOUS FISTULA; ARTICLE; AUTOMATION; CASE REPORT; CYTAPHERESIS; ERYTHROCYTAPHERESIS; ERYTHROCYTE TRANSFUSION; HUMAN; IRON OVERLOAD; MALE; SICKLE CELL ANEMIA; VASCULAR ACCESS; APHERESIS; ARTERIOVENOUS SHUNT; CEREBROVASCULAR ACCIDENT; METHODOLOGY; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ANEMIA, SICKLE CELL; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD COMPONENT REMOVAL; CEREBROVASCULAR ACCIDENT; ERYTHROCYTE TRANSFUSION; HUMANS; MALE; RECURRENCE; TREATMENT OUTCOME;

EID: 0036191089     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.2002.00346.x     Document Type: Article

References (8)

1. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients
2. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients
3. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease
4. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state
5. Central venous catheter related thrombosis
6. Transfusion and exchange transfusion in sickle cell anemia with particular reference to iron metabolism
7. The natural history of stroke in sickle cell disease
8. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease